The Zurich based group at Homburger assists a diverse client base of well-known international pharma and healthcare giants, notably including Novartis, Sandoz, and Sanofi Aventis. The team displays deep bench strength across a variety of areas, including patent enforcement actions against generics producers, and joint ventures. Practice co-head Dieter Gericke has longstanding expertise in transactional matters, including public takeovers, shareholder activism, and public M&A. Co-head Andri Hess regularly acts in IP disputes and arbitrations, whilst maintaining a strong focus on pharma regulatory issues and IT. Co-head Richard Stäuber is known for his vast knowledge of Swiss and European competition issues, acting for clients in merger control proceedings, distribution arrangements, and investigations.
Key clients
- Roche
- Novartis
- Sandoz
- Syngenta
- Eli Lilly
- Nestlé
- CSL
- Illumina
- Molecular Partners
- Santhera Pharmaceuticals
- PPF Group
- Vifor Pharma
- ADC Therapeutics
- Bristol Myers-Squibb
- Edwards Lifesciences
- VectivBio
- SOPHiA GENETICS
- ArchiMed
- Therachon
- Zur Rose Group
- Spectris
- Atara Biotherapeutics
- Apellis
- Straumann
- Sonova
- Siegfried
- Biognosys
- Covis Pharma
- IMA Medtech
- BIOBank
- Addex Therapeutics
- Strides Pharma Science
- Sanofi Aventis
- Octapharma
- Horizon Therapeutics plc
- PHOENIX Pharma
- Nice & Green
- Amedis
Work highlights
- Advised Zur Rose Group on regulatory matters in the sale of its Swiss business to Migros’ Medbase, and represented the client in merger control proceedings
- Acted for Novartis, securing a landmark judgment in enforcing patents against generic JADENU (deferasirox) products.
- Advised Santhera on its transformative exclusive outlicensing for vamorolone to Catalyst Pharmaceuticals.
Lawyers
Practice head
The lawyer(s) leading their teams.
Dieter Gericke, Andri Hess, Richard Stäuber